Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment

Antidiabetic medication may modulate the gut microbiota and thereby alter plasma and faecal bile acid (BA) composition, which may improve metabolic health. Here we show that treatment with Acarbose, but not Glipizide, increases the ratio between primary BAs and secondary BAs and plasma levels of unc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Yanyun, Wang, Xiaokai, Li, Junhua, Zhang, Yifei, Zhong, Huanzi, Liu, Ruixin, Zhang, Dongya, Feng, Qiang, Xie, Xiaoyan, Hong, Jie, Ren, Huahui, Liu, Wei, Ma, Jing, Su, Qing, Zhang, Hongmei, Yang, Jialin, Wang, Xiaoling, Zhao, Xinjie, Gu, Weiqiong, Bi, Yufang, Peng, Yongde, Xu, Xiaoqiang, Xia, Huihua, Li, Fang, Xu, Xun, Yang, Huanming, Xu, Guowang, Madsen, Lise, Kristiansen, Karsten, Ning, Guang, Wang, Weiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702614/
https://www.ncbi.nlm.nih.gov/pubmed/29176714
http://dx.doi.org/10.1038/s41467-017-01682-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702614/
https://www.ncbi.nlm.nih.gov/pubmed/29176714
http://dx.doi.org/10.1038/s41467-017-01682-2

Ejemplares similares